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MYELOMA PROTEINS AND ANTIBODIES*
HENRY G. KUNKEL
The Rockefeller lnstitttte, New York, New York
I.

A

INTRODUCTION

represents one disease which has very

£1... aptly been termed "an experiment of nature" because of the
GAMMAGLOBULINEMIA

large body of widely useful information gained through clinical
investigation of patients with this condition. Another such disease,
at the opposite extreme with tremendous overproduction of r
globulin, is multiple myeloma, which shows promise of proving
of even greater utility and represents another area where clinical
investigation has much to offer for the elucidation of a variety of
basic problems in immunology.
There is no more intriguing question in biology today than that
of antibody specificity. How is it acquired from the antigen and
what are the permutations and combinations of the y-globulin
molecule which endows it with an individual specificity? It is a
problem, however, that has proved uniquely difficult to attack,
primarily because of the difficulty in isolating in workable quanti
ties antibodies to single antigenic determinants. In fact, valid
question remains whether this has ever been accomplished even
in small amounts. As an alternative, the readily available myeloma
proteins have been and will certainly continue to be utilized.
The possibility exists that they themselves represent individual
antibodies, the products of the single plasma cells that gave rise
to the clone of myeloma cells. Some support for this concept has
arisen recently from the discovery of antibody-like activity for a
number of the Waldenstrom type macroglobulins (Kritzman
et al., 1961 ) . Irrespective of the final settlement regarding this
question, one conclusion has become apparent to all who have
worked with these and the related Bence-Jones proteins and
* Lecture delivered March 16, 1964.
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macroglobulins, and that is, that every piece of information gained
from their study, no matter how seemingly irrelevant, is directly
applicable to the problem of normal ,,-globulin and individual
antibodies. This point represents the main theme of this paper.
Bence Jones proteins were .first described in 1845, more than
a hundred years ago. The story of how Sir James Watson sent
a bottle of urine to Dr. Henry Bence Jones for special study has
been recounted many times in traditional British fashion. The
equally and perhaps more significant discovery of the myeloma
protein in the serum and its distinction from the urinary Bence
Jones proteins by Geschickter and Copeland ( 1928) at Johns
Hopkins Hospital, has scarcely been noticed. Their study initiated
an interest in the relationship of the serum and urinary protein
which is certainly a lively one at the present day. Mention also
should be made of the early work of Dr. Stanhope Bayne-Jones
on Bence Jones proteins ( 1922); the correspondence in names can
scarcely have been fortuitious. He was one of the first to carry
out immunological studies. In fact in reading through this work
recently, it was rather shocking to see how similar certain of his
conclusions on immunological subgroups were to some presum
ably original ones in a recent paper of ours. Progress in the
myeloma field shiften from Baltimore to New York with the
now classical studies of Gutman and associates (1941 ) on the
physical characteristics of the serum and urinary proteins. In the
more clinical area, Dr. Snapper assembled a vast amount of useful
information and stimulated interest in a variety of therapeutic
possibilities (Snapper et al., 1953).
Our own interest in this field approximately fifteen years ago
with studies employing antisera to the newly available Fr II
,,-globulin (Kunkel et al., 1951). This work indicated that the
myeloma proteins were closely related antigenically to normal
,,-globulin. The earlier investigators were more impressed with
the antigenic uniqueness of the myeloma and Bence Jones pro
teins, a topic which is of considerable current interest and to
which I will return later. Reactions with normal serum and
,,-globulin had been dismissed as due to contaminants. The con
cept of paraproteins or abnormal proteins was firmly entrenched
and even today continues to have a few adherents.
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Figure 1, taken from these early studies, shows precipitin
curves obtained from the reaction of an antiserum to Fr II
y-globulin and dilutions of two myeloma sera and one normal
serum. The point of equivalence is shifted markedly to the left
for the myeloma sera. The only explanation for these findings
was that the myeloma proteins in these sera reacted with the
anti-Fr II antibodies. In fact, the concentration of the myeloma
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FIG. 1. Precipitin curves of serial dilutions of two myeloma sera and one
normal serum with antiserum to Fr II ')'-globulin indicating the reaction of
antibodies to normal ')'-globulin with the myeloma proteins. From Kunkel
et al. (1951).

protein could be grossly quantitated from such curves. The lower
equivalence peaks for the myeloma sera indicated that not all
the antibodies to Fr II were reacting with these proteins. If one
makes a mixture of myeloma proteins, making sure that group I
and group II types are in the ratio found in normal y-globulin,
the resulting precipitin curve is very analogous to that of Fr II.
This is also true of other properties that have been examined.
Extensive studies of this type (Slater et al.} 1955; Mannik and
Kunkel, 1962; Mannik and Kunkel, 1963a Harboe et al.} 1962a)
along with those of Deutsch and associates ( 1956), have led to
the concept that y-globulin represents a composite mixture of
proteins which individually closely resemble the myeloma pro-
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teins. This is illustrated semidiagrammatically for orientation pur
poses in Fig. 2. The broad distribution of y-globulin in the elec
trophoretic spectrum of serum is illustrated along with hypothet
ical myeloma proteins distributed over the same mobility range
as for the normaly-globulin. Figure 2 illustrates only one dimen
sion of difference among these proteins, that is, electrophoretic
mobility. It has become evident that many others exist and that
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Frc. 2. Schematic drawing illustrating the broad distribution of -y-globulin
m the zone electrophoresis pattern and the distribution of individual rnyeloma
proteins over a similar area.

normal y-globulin must be considered a myriad of different
proteins each of which may have a myeloma counterpart.
II .

/3 2A

.
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Even in the earliest antigenic studies it became apparent that
approximately one-fourth of the myeloma proteins behaved very
differently and were very distantly related to Fr II. There was
another component in normal serum which migrated between
they and f3 area to which these myelomas were very similar. This
finding (Slater et al., 1955) led, following the development of
immunoelectrophoretic techniques, to the delineation of a separate
class of immunoglobulins, the /32A or '}'rA class ( Heremans, 1960;
Tomasi and Zigelbaum, 1963).
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In normal serum the /32A class of immunoglobulins represents
a minor component, of approximately one-fourth the concentra
tion of the major 7 S type of y-globulin. However, in other body
fluids particularly external secretions, it frequently represents the
dominant type of immunoglobulin (Tomasi and Zigelbaum,
1963). Current interest has centered on the assignment of anti
body activity to this class and an understanding of its biological
significance. A relatively simple procedure for detecting /32A
antibodies has been applied to the isoagglutinins (Kunkel and
Rockey, 1963). Washed specific precipitates between blood group
A substance and human serum containing anti-A antibodies are
dissolved in antigen excess and applied to the central wall of
an agar plate. Specific antisera to the various immunoglobulins
in the outside wells delineate the antigenic character of the anti
body. /32A antisera that react only with this class of immuno
globulin give distinct lines with the dissolved antibody from most
sera. Quantitative analysis indicates that in most instances less
than 20% of the antibody was of the /32 A type. Recently, several
anti-B antibodies have been obtained from human sera which
show the /32 A type as the dominant species. Other workers have
also described /32A antibodies utilizing a variety of methods
(Fireman et al., 1963; Fahey and Goodman, 1964).
Another more complex procedure that has proved useful for
the delineation of the type of antibody in specific sera has been
density gradient ultracentrifugation or combination of this tech
nique with chromatography (Rockey and Kunkel, 1962). Figure
3 illustrates the results for one anti-A serum separated first by
chromatography and then by density gradient ultracentrifugation
of the chromatographic fractions. Three types of antibody activity
are shown which differ both in chromatographic and in sedimen
tation characteristics. These represent the usual 7 S and 19 S types
plus an additional type with an intermediate sedimentation rate.
The latter type are the subject of considerable current interest.
Most of the /32A antibodies in the isoagglutinin system show this
property. The subject is confused, however, by the additional
occurrence of isoagglutinins of intermediate sedimentation rate
which are not of the /3 2 A class but appear to be polymers of
ordinary 7 S y-globulin. This type was observed in many anti-A
sera.
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FIG. 3. Distribution of anti-A antibody activity following density gradient
ultracentrifugation of three column fractions of serum. The solid lines represent
the protein curves and the bars the antibody activity. The upper pattern repre
sents 7 S antibody, the lower pattern 19 S antibody, ant the middle pattern
antibody of intermediate sedimentation rate. From Rockey and Kunkel ( 1962).

The finding of /32A antibodies of intermediate sedimentation
properties was expected in view of the wide occurrence of /32A
type myeloma proteins which exist in polymeric forms (Laurell,
1961). As in the case of the Waldenstri::im macroglobulins these
appear to represent basic four-chain structures which are sec-
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ondarily linked by readily split disulfide bonds; these polymers
are very variable in size, however (Mannik and Kunkel, 1964)
( cf. Fig. 4). The bulk of our knowledge concerning the /32A
class proteins has arisen from the study of the myeloma proteins,
and in fact it is highly doubtful that we would even recognize
today this important class of antibodies if it had not been for the
striking properties of the myeloma proteins of this type.
III.

CHAIN STRUCTURE OF y-GLOBULIN AND
THE GENETIC FACTORS

One of the major recent developments in the y-globulin field
has been the elucidation of the multiple chain structure of these
proteins. This began with observations on the dissociation of
Waldenstrom macroglobulins with sulfhydryl compounds and
has been extended to include all the immunoglobulins. It is now
apparent that each of these proteins is made up of two types of
polypeptide chains that differ markedly from each other. Dr.
Gerald Edelman, who began this work in our laboratory, has
been responsible for many of these important developments.
After reduction with agents such as mercaptoethanol, the chains
of all the immunoglobulins can be separated by a variety of
methods. It is perhaps brought out most clearly by starch gel
electrophoretic separation (Edelman and Poulik, 1961), but the
chains also can be separated by a variety of other methods
(Fleischman et al.) 1963). Here again work with myeloma pro
teins aided considerably, and the sharp banding of the L and H
chains in gel separations were first evident with these proteins.
A dramatic finding which arose as a consequence of this work
is that the Bence Jones proteins correspond to the free L poly
peptide chains from the same patient (Edelman and Poulik,
1961). The recent observation (Franklin et al.) 1963; Osserman
and Takatsuki, 1963) of patients with a myeloma-like picture
who produce very large amounts of material resembling free H
chains in some ways completes the picture. Both the L and H
chains seem to appear in disease in the uncombined state, but thus
far never in the same patient.
A primary question that arose from the elucidation of the
chain picture or ordinary y-globulin, was what relationship did
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the H and L chains have to the other immunoglobulins. The
answer has come from a variety of sources, but perhaps most
strikingly from investigations of the genetically determined fac
tors in y-globulin. At least twelve different genetic types of
human y-globulin can be distinguished in different individuals.
These have been studied extensively by human geneticists, and
it is clear that the factors responsible are determined by genes
present at a number of different loci. Two of these, the Gm and
Inv loci, are clearly separate.
TABLE I
LOCALIZATION OF THE Gm AND Inv FACTORS IN THE FRAGMENTS OF
-y-GLOBULIN PRODUCED BY PAPAIN
Phenotype
Donor

Preparation

Gm

Inv

L. B.

Whole -y-globulin
F fragment
S fragment
Whole -y-globulin
F fragment
S fragment
Myeloma protein
F fragment
S fragment

a+ba+ba-ba+b+
a+b+
a-ba+ba+ba-b-

a-b+
a-ba-b+
a+b+
a-ba+b+
a-b+
a-ba-b+

R.T.
L. O.

The Gm and Inv determinants were initially localized to dif
ferent portions of they-globulin molecule (Harboe et al.) 19626;
Franklin et al.) 1962) through studies of the S and F fractions
of y-globulin produced by papain splitting (Table I). This work
along with studies of the Inv factors in Bence Jones proteins
indicated that these genetic determinants were on different poly
peptide chains.
The direct demonstration of the various genetic factors on the
isolated chains has been hampered considerably by technical
problems involved in the isolation of the L and H chains in com
pletely pure form. In many instances the H chains in particular
are contaminated by L chains which can be detected antigenically.
In addition, the H chains are in general very insoluble and are
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difficult to work with. In fact the best solvent for the H chains
is a solution of L chains. The strong affinity of these chains for
each other even when the SH groups are blocked with iodoace
tamide represents a dramatic phenomenon and makes the forma
tion of hybrid molecules of various isolated L and H chains com
paratively easy. At present there are no published data available
concerning the direct localization of the GM and Inv characters
to the L and H chains. Our laboratory has had limited results for
a number of years which confirmed the previous experiments
TABLE II
Gm AND Inv PHENOTYPES OF THE WHOLE -y-GLOBULIN AND L AND H
CHAINS FROM DIFFERENT INDIVIDUALS
Native protein

L chains

H chains

Preparation

Gm

Inv

Gm

Inv

Gm

Inv

Normal -y-globulin

a+b-x+
a+b-x+
a-b+xa-b+x-

aaaa+

a-b-xa-b-xa-S-xa-b-x-

aaaa+

a+b-x+
a+b-x+
a-b+xa-b+x-

aaaa-

Myeloma protein

a+ba-ba-ba-ba-b-

aaaaa+

a-b-xa-b-xa-b-xa-b-xa-b-x-

aaaaa+

a+ba-ba-ba-ba-b-

aaaaa-

with other methods. This also has been the case with other
laboratories. Recently, Dr. Mart Mannik in our group isolated
the L and H chains from various preparations of normal
y-globulin and myeloma proteins, utilizing essentially the method
of Fleischman et al., ( 1963). These were used primarily for
hybridization experiments, but some data on the better prepara
tions were obtained concerning the genetic factors. Table II in- .
dicates certain of the results obtained. Unfortunately the more
widely prevalent Inv ( b) factor could not be measured because the
reagent for this system is no longer available. However, it was
clear that the Gm factors were found only on the H chains, and
the Inv factors only on the L chains.
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The localization of these genetic factors to the other immuno
globulins was made relatively easy through the use of myeloma
proteins and Waldenstrom type macroglobulins. Clear-cut re
sults were obtained which demonstrated that the Gm determinants
were limited to 7 S y-globulin whereas the Inv determinants
extended to all classes of immunoglobulins including the Bence
Jones proteins. Table III summarizes such results from our
laboratory.
TABLE III
Gm AND Inv TYPES OF ISOLATED MYELOMA PROTEINS, MACROGLOBULINS,
AND URINARY BENCE ]ONES PROTEINS

Class of
protein
7 S -y
19 S -y
f32A
Bence Jones

Gm type

Inv type

a+b- a+b+ a-6+ a-6-

a+b- a+b+ a-6+ a-6-

15

0

0
0
0

0
0
0

2
0
0
0

30

6
15

11

3
0

1
1

0
0
0
0

17

6

2

4

9
5

5
5

Experiments were also carried out on the 19 S proteins of six
normal sera of different phenotypes and compared with the 7 S
y-globulin isolated from the same sera ( Harboe and Osterland,
1963). This was a very laborious task ·and has not as yet been
completed for the /32A proteins (Table IV). Again, Gm activity
was completely absent in the isolated 19 S material, while the Inv
TABLE IV
GENETIC TYPES OF 7 S AND 19 S -y-GLOBULIN
PURIFIED FROM Six NORMAL SERA
Serum
1
2
3
4

5

6

7 S -y-globulin
Gm(a+b+)
Gm(a+b+)
Gm(a+b+)
Gm(a+b+)
Gm(a+b+)
Gm(a-6+)

Inv(a+b+)
Inv(a+b+)
Inv(a-6+)
Inv(a-6+)
Inv(a-6+)
Inv(a-6+)

19 S -y-globulin
Gm(a-6-)
Gm(a-6-)
Gm(a-6-)
Gm(a-6-)
Gm(a-6-)
Gm(a-6-)

Inv(a+b+)
Inv(a+b+)
Inv(a-6+)
Inv(a-6+)
Inv(a-6+)
Inv(a-6+)
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type corresponded in each case to that for the 7 S fractions. In
fact, the presence of Gm activity proved to serve as a useful tool
in detecting contamination of 19 S fractions by 7 S y-globulin.
Thus the L chains for each class of immunoglobulins must be
very closely related and appear to be under similar genetic control.
The H chains, however, are known to be completely different
antigenically and in turn appear to be under independent genetic
control. Recent observations on the H chain subgroups of 7 S
7S

19S

f32A

s
s
I

I
s
s
I
I

X(l-4)

s
X(6)

I

FIG. 4. Schematic diagram of the tentative chain structure of the three types
of immunoglobulins. The polymeric form of the 19 S and of some {J2A proteins
is illustrated. Each type has similar L chains and different H chains.

y-globulin ( Grey and Kunkel, 1964) indicate that each of
these contain different genetic determinants controlled by genes
at closely linked loci (Kunkel et al., 1964). This work has
led to the concept of a cluster of closely linked and partially
similar structural genes in a "H chain" region of the chromosome.
It seems likely that the loci involved in the H chains of 19 S and
/3 2A immunoglobulins are also closely linked to the 7 S group..
Figure 4 illustrates a tentative chain structure diagram for the
three classes of immunoglobulins based on the antigenic and
genetic studies mentioned above as well as starch gel elec
trophoresis analyses (Edelman, 1963; Carbonara and Heremans,
1963). A variety of observations indicate that the 19 S proteins
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represent polymeric forms of a basic four-chain unit similar to
7 S y-globulin. There are approximately six basic units in the
19 S class, linked by single disulfide bonds attached to the H
chains (Kunkel et al.J 1961). The /32A class is very incompletely
studied at present but reduction experiments suggest a similar
situation to that occurring in the 19 S class. However, in this
group there is considerably greater variability in the degree of
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FrG. 5. Zone electrophoresis pattern of a serum containing a high concentra
tion of myeloma protein of relatively slow mobility. The normal -y-globulin
in tubes 6-12 is Gm(a + b+) whereas the myeloma protein is Gm(a + b -) .
From Harboe et al. (1962a).

polymerization ranging from a monomeric form to quite large
polymers. A great heterogeneity of these forms has been ob
served in different myeloma proteins of the /32 A class.
Another finding that arose from the studies of the genetic
characters in isolated myeloma proteins was the selective oc
currence in these proteins of only one of each pair of apparent
allelic factors in heterozygous individuals. This is illustrated in
Fig. 5, showing the method of analysis for the Gm factors in both
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the myeloma protein and the normal y-globulin of that in
dividual ( Harboe et al., 1962a). Each tube was brought to the
same protein concentration (1 mg. /ml.) for the assay. No
myeloma protein typed out as Gm (a+b+) or Inv (a+b+), al
though Gm and Inv factors could be detected in the same mye
loma. This series has been extended considerably now from work
in various laboratories, and no exception to this rule has been
found. This also applies when measurements are made for the
new Gm (f) factor which behaves like an allele of Gm (a) . Most
of the myeloma proteins which were previously Gm negative
are positive in the Gm (f) system.
The interpretation of these data is subject to some problems in
the light of recent observations on H-chain subgroups demon
strating that Gm (b) and Gm (a) may not be the products of
allelic genes (Kunkel et al., 1964). However, the occurrence
of Gm (f) in the same subgroup of 7 S y-globulin as Gm (a)
raises the possibility that these two factors may be controlled by
true alleles, and these factors are also never found in the same
myeloma proteins in heterozygous individuals.
Studies with isolated antibodies, carried out primarily by Dr.
James Allen in a collaborative study with Dr. Elvin Kabat, indi
cate that many of these show a picture very similar to the myeloma
proteins with selective occurrence of the genetic factors and fre
quent absence of characters which occur in the individual's
y-globulin (Allen et al., 1964). The problem here is compli
cated by the fact that most of the antibodies studied are directed
against multiple determinants. However, every indication points
to the fact that the behavior of the best preparations approach
closely that of the myeloma proteins.
These variable ratios of genetic factors in presumed hetero
zygous individuals indicate that antibody-producing cells must
differ in their synthesis of proteins carrying these factors possibly
reaching the extreme picture observed for the myeloma proteins.
Experiments with the rabbit allotypes indicate a similar picture
with variable ratios of genetic factors in different isolated anti
bodies (Rieder and Oudin, 1963). However, recent fluorescent
antibody studies for one allelic system have not shown differential

232

HENRY G. KUNKEL

labeling for one or the other factor in heterozygous animals ( Col
berg and Dray, 1964). This finding does not explain the variable
ratios in different rabbit antibodies and does not fit with the
findings for humans. It will be most important to resolve these
apparent discrepancies.
IV. SUBGROUPS OF 7 S y-GLOBULIN INVOLVING
L CHAINS AND H CHAINS

In addition to the genetic differences in 7 S y-globulin multiple
subclasses of 7 S y-globulin have been found that appear to be
present in all individuals. Most antisera to normal y-globulin give
a single band with Fr II y-globulin and normal serum by im
munoelectrophoretic analysis. This led many early workers, not
influenced by the antigenic heterogeneity of the myeloma pro
teins, to consider y-globulin antigenically homogeneous. How
ever, many antisera clearly suggested that this was not the case.
Particularly striking were antisera to /32A myeloma proteins and
Waldenstrom macroglobulins, which frequently showed double
lines when allowed to react with Fr II (Edelman et al., 1960).
This double-line phenomenon suggested two major classes of
y-globulin. However, despite considerable effort it proved ex
tremely difficult to demonstrate this satisfactorily. The elucida
tion of the phenomenon came through an appreciation of a rela
tionship to the two classes of Bence Jones proteins that had long
been known. Antisera to these Bence Jones proteins divided all
classes of immunoglobulins into two groups. It had been known
ever since the work of Bayne-Jones ( cf. Bayne-Jones and Wilson,
1922) that at least two major antigenic groups of Bence Jones
proteins existed. These were clearly brought out through the
studies of Korngold and Lipari ( 1956). Antisera to each type
were completely specific with no evidence of a cross reaction be
tween the two. This clear difference has also become apparent
through recent peptide analyses (Putnam, 1962). There are no
recognizable tryptic peptides that are shared. Despite these strik
ing differences, both types show the classical solubility properties
of Bence Jones proteins.
Specific antisera to each type of Bence Jones protein divided
7 S myeloma proteins, /32A myeloma proteins, and Waldenstrom
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macroglobulins into two distinct groups termed groups I and II
(Mannik and Kunkel, 1962; Fahey, 1963) (Fig. 6). Fr II
y-globulin as well as the y-globulin from single normal in
dividuals also consisted of a mixture of the two types which
could be quantitated (Mannik and Kunkel, 1963a). Figure 7
illustrates the method employed in our laboratory utilizing l 131labeled y-globulin. Approximately 60% of the y-globulin pre
cipitated with antisera to group I Bence Jones proteins, and apGroup I
?Sy-Globulins

19Sy-Globulins

---L I
H 7Sr----

H 7S y -------_- LII

H1sy---
---L I

H1s r ---
---LII

H 19Sy Hr,-&-·---LI
..,., .. ,.. ··I
H19S y •A .1., ........ ·&-··J
---L i

,B2A-Globul ins

H,82A
H,B2A

rL -Globulins

Group II

---Lr
---LI
---Li

H19S y I·
H19S y •�·

H .82A
H,82A

---L II
., ·�•..•_.,. ···-4

=z:=.m

�LII
---LII
---LlI
---LII

FIG. 6. Diagram of the different immunoglobulins illustrating the distribution
of group I and group II L chains among all types. The ')'L refers to the free L
chains found in the urine (Mannik and Kunkel, in press).

proximately 30% with the antisera to group II proteins. The com
bined antisera produced exact additive effects indicating that the
individual molecules were not both group I and group II. As
expected, isolated L chains from y-globulin contained the two
types of antigenic determinants, and these could be similarly
divided by means of the Bence Jones antisera. In fact isolated
L chains reacted considerably better with these antisera than did
the whole y-globulin molecules. This was due to the fact that
many of the antibodies were directed against L-chain determinants
that were blocked by H chains in the combined form of y-globulin.
The simple addition of H chains to L chains in recombination
experiments demonstrated this phenomenon (Kunkel, Solomon,
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and Grey unpublished observations) . In the course of this work it
was apparent that group II antisera were more heterogeneous than
the group I types and contained strong specificities other than
those to the group antigens.
It was of considerable interest than the 60: 30 ratio of group I
to group II molecules in y-globulin was almost identical to the
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FIG. 7. Precipitin curves with 1 -labeled Fr II and group I and group II
antisera (left), indicating the percentage of protein in each group. x--x
indicates protein, and x---x indicates percentage of radioactivity precipitated
by a group I antiserum; o--o and o---o indicate the same for a group II
antiserum.
On the right, the curves indicate the protein and radioactivity precipitated
by a mixture of group I and group II antisera (o--o, o---o) and by an
antiserum to whole Fr II (x--x, x-x). From Mannik and Kunkel
(1963a).

incidence of group I versus group II myeloma proteins ( Mannik
and Kunkel, 196 3a). No evidence was obtained for a significant
variation in this ratio in the y-globulin of individuals of various
ethnic and geographical groups. However, the study of isolated·
antibodies indicated considerable deviations in this ratio ( Man
nik and Kunkel, 19636). Figure 8 illustrates the marked dif-

MYELOMA PROTEINS AND ANTIBODIES

235

ference between two antiteichoic acid antibodies. Several anti-A
antibodies stood out in consisting of primarily group II molecules.
The cold agglutinins of seven cases of cold agglutinin disease
were entirely group I. It appeared as if antibodies to single de
terminants might very well consist of purely one group or the
other analogous to the myeloma proteins, Waldenstrom macro
globulins and Bence Jones proteins.

FIG. 8. Two agar slides showing the reaction of serial dilutions of two iso
lated antiteichoic acid antibodies with group I and group II antisera. Upper
trough in each slide contains a group II antiserum, and the lower trough a
group I antiserum. The upper antibody shows greatest reactivity with the
group I antiserum while the lower shows a greater reactivity with the group II
antiserum. From Mannik and Kunkel ( 19636).

As in the case of the L chains, antigenic analyses have demon
strated a number of subgroups which reflect differences in the H
chains of 7 S y-globulin. These H-chain differences are not as
complete as those for the group I and II L chains and common
antigens have always been detected. Four H-chain subgroups
have been delineated through the use of specific antisera to in
dividual myeloma proteins ( Grey and Kunkel, 1964). Follow
ing absorption with myeloma proteins of heterologous subgroups,
specific reactions for the group concerned can be obtained. Tern-
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porary names have been assigned these subgroups according to
the initial myeloma protein employed as antigen in the produc
tion of the specific antisera. Quantitative precipitin studies with
such antisera have permitted an estimate of the approximate
quantity of the various subgroups in pooled as well as individual
specimens of isolated y-globulin. The major We group consists
of approximately 60% of the total y-globulin in Fr II, and the Vi
group, approximately 8o/o. The Ne group and Ge group have
not been as closely quantitated, but it is clear that the Ne group
ranges between 10 and 20% and the Ge group represents a
minor fraction. These figures agree again with the approximate
incidence of myeloma proteins of each of the subgroups. A num
ber of studies with isolated y-globulin of representative sera
from different ethnic and geographic groups have not shown
any consistent difference in the relative quantity of these sub
groups.
The most interesting finding arising from the study of these
subgroups is that each appears to contain its own set of genetic
factors (Kunkel et al.J 1964). In fact the two major factors
in the Gm system proved to be on different group proteins.
Gm(a) was found only in We group myeloma proteins, and
Gm(b) only in Vi group proteins. The other two groups con
tained no currently recognizable Gm factors.
V. INDIVIDUAL ANTIGENIC SPECIFICITY OF MYELOMA
PROTEINS AND ISOLATED ANTIBODIES

There is one further subject which is particularly relevant with
regard to the variation in the chains of y-globulin, and this con
cerns the individual antigenic specificity of myeloma proteins. It
has long been known that antisera to single proteins of this type
react to a greater degree with the homologous antigen than with
other myeloma proteins or normal y-globulin (Slater et al.
1955). This has led many to the conclusion that these are ab
normal proteins. The individual specificity is brought out
strikingly with many antisera by spur formation of the homol
ogous myeloma protein over other myeloma proteins and prepara
tions of y-globulin. Great variation is observed from one anti
serum to another in the extent of this specificity, although it is
J
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found in the great majority of antisera. Absorption experiments
with pooled y-globulin also bring out this great variation. Some
antisera lose this specificity entirely after absorption with large
amounts of ,,-globulin, others lose it partially, and a few are very
little affected. Figure 9 shows an example of the effect of various
concentrations of pooled ,,-globulin on the specificity of myeloma
Vi with anti-Vi antiserum. Absorption with 2 mg. of ,,-globulin
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FrG. 9. Precipitin curves of isolated myeloma Vi with anti-Vi antiserum
absorbed with increasing amounts of pooled '}'-globulin. The amount of protein
precipitated at equivalence decreases but some individual specificity remains
even after the addition of SO mg. of Fr II per milliliter of antiserum.

removes the reactivity with ,,-globulin and myeloma proteins of
heterologous groups. Absorption with 10 mg. removes the
specificity for Vi group proteins and leaves only the individual
specificity. Absorption with 50 mg. reduces this partially and
100 mg. slightly further, but some individual specificity remains.
With many antisera, continued absorption with large amounts
of ,,-globulin gradually lowered the precipitin curve for the in
dividual specific reaction. It appeared as if there frequently
existed determinants in small amounts in pooled ,,-globulin that
resembled those of the antigen.
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The localization of the specificity on the chains of y-globulin
has proved quite difficult. In certain instances the specificity can
be demonstrated on the L chains (Mannik and Kunkel, 1963c)
and in others on the H chains. However, in most instances it
requires combination of the H and L chains to be evident ( Grey
et al., to be published). The quaternary structure of the molecule
appears to be most important m this type of antigenic indi
viduality.
A large number of studies of isolated antibodies over the
past twenty years have led to the conclusion that these are not
antigenically distinct and give rise to antibodies closely analogous
to those obtained with normal y-globulin. In view of the striking
findings regarding individual specificity in the myeloma field, this
problem was reinvestigated with some new isolated antibodies
against limited antigenic determinants. Animals were immunized
with isolated anti-A, anti-B, anti-dextran, anti-levan, and anti
teichoic acid antibodies. Individual specificity was found in a
number of instances (Kunkel et al., 1963). Figure 10 illustrates
one example of this specificity for an anti-A antibody. Antisera

FIG. 10. Agar plate analysis showing the specific reaction of isolated antibody
Th with anti-Th antiserum (A). Peripheral wells 2-5 contain ,y-globulin
preparations of different types, and wells 6-12 contain heterologous isolated
anti-A antibodies. The antiserum (A) was absorbed with 5 mg. Fr JI per milli
liter of serum. From Kunkel et al. ( 1963).
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to two different anti-A antibodies showed complete individual
specificity and both of these failed to react in a similar fashion
with any of fifteen other isolated anti-A antibodies. This has also
proved true even more strikingly with the 19 S cold agglutinins.
The accumulated evidence indicates that this individual specificity
is unrelated to the antibody site of these antibodies.
Thus in this final distinct characteristic isolated antibodies be
haved in all respects like myeloma proteins. There have been no
exceptions to this rule although it is of course important to con
tinue to be alert to this possibility.
VI. DISCUSSION

Any discussion of antibodies would have to be considered in
complete if it did not offer some hypothesis on that question that
has certainly had its share of hypotheses, the mechanism of anti
body formation. Perhaps two of the points described have special
relevance and offer some clues to at least the latter stages of anti
body synthesis. The first is the large number of groups, sub
groups, and sub-subgroups that exist for both the H and L chains
with evidence of distinct chemical differences. The second con
cerns the commitment of the individual cell or clone of cells to a
selective type of polypeptide chain. Evidence is available that
group I and group II L chains can be produced by the same cell.
Yet, after antibody synthesis begins, there is selective synthesis of
these types. We know that the cell has the capacity to produce
the allelic genetic factors in heterozygous individuals, yet the
committed cell produces very variable ratios of these factors. It
would seem as if the two chains most complementary to the anti
gen are selected for increased synthesis, probably by a de-repres
sion mechanism, from a huge number that the cell has the capacity
to make, or already produces in small amount, with continued
repression of the synthesis of the remainder. The two selected
chains then come together producing the final four-chain struc
ture with even greater complementarity.
Such a concept places a dominant role on the individual cell
in determining the type of protein chosen for synthesis and differs
from various clonal selection theories. The multiplicity of genetic
factors. already discovered along with the clear indication for

240

HENRY G. KUNKEL

many more as yet undetected, offers a· tremendous source of
heterogeneity for both the L and H chains. This potential is
possessed by each cell and in some unknown fashion might be
utilized by the cell in the production of proteins of different
structures and specificities. In a process of this kind it would seem
unlikely that any two individuals would ever produce exactly
the same type of antibody even to the same limited antigenic de
terminant. The results obtained with the individual antigenic
specificity of various antibodies suggest that this indeed is the
case.
The time is near for a large-scale chemical attack on this prob
lem, and the myeloma and Bence Jones proteins will undoubtedly
serve as the subject materials. The antigenic approach described
above, which has served to delineate subgroups involving both
the L and H chains and multiple genetic factors, has thus aided in
providing an overall picture of this unique and complex system
and has furnished a more rational basis on which the chemistry
can eventually evolve.
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